Customer Service: (855) 848-6626 | 8:00 a.m - 4:30 p.m. PST | Receive a Free Mask with Orders over $300

Human peripheral blood monocytes were stained with 5 uL (0.5 ug) PE Anti-Human CD86 (50-0869) (solid line) or 0.5 ug PE Mouse IgG2b isotype control (dashed line).
  • Human peripheral blood monocytes were stained with 5 uL (0.5 ug) PE Anti-Human CD86 (50-0869) (solid line) or 0.5 ug PE Mouse IgG2b isotype control (dashed line).
  • PE Anti-Human CD86 (B7-2) (IT2.2)

PE Anti-Human CD86 (B7-2) (IT2.2)

Cat No. Size Price Quantity
50-0869-T025 25 tests $67.00
50-0869-T100 100 tests $184.00

Description

The IT2.2 antibody reacts with human CD86, also known as B7-2, an 80 kDa cell surface protein which is a ligand for CD28, a co-stimulatory receptor for the T cell receptor (TCR). CD28 can also bind a second B7 ligand known as CD80 (B7-1). Both CD80 and CD86 are expressed on activated B cells and antigen-presenting cells. These ligands trigger CD28 signaling in concert with TCR activation to drive T cell proliferation, induce high-level expression of IL-2, impart resistance to apoptosis, and enhance T cell cytotoxicity. The interaction / co-stimulatory signaling between ≥ ≥ ≥ the B7 ligands and CD28 provides crucial communication between ≥ ≥ ≥ T cells and B cells or APCs to coordinate the adaptive immune response.

The IT2.2 antibody may be used as a marker for CD86 expression on B cells, macrophages, and dendritic cells. It is reported to be cross-reactive with Rhesus, Cynomolgus and Common marmoset CD86.

View More

The IT2.2 antibody reacts with human CD86, also known as B7-2, an 80 kDa cell surface protein which is a ligand for CD28, a co-stimulatory receptor for the T cell receptor (TCR). CD28 can also bind a second B7 ligand known as CD80 (B7-1). Both CD80 and CD86 are expressed on activated B cells and antigen-presenting cells. These ligands trigger CD28 signaling in concert with TCR activation to drive T cell proliferation, induce high-level expression of IL-2, impart resistance to apoptosis, and enhance T cell cytotoxicity. The interaction / co-stimulatory signaling between ≥ ≥ ≥ the B7 ligands and CD28 provides crucial communication between ≥ ≥ ≥ T cells and B cells or APCs to coordinate the adaptive immune response.

The IT2.2 antibody may be used as a marker for CD86 expression on B cells, macrophages, and dendritic cells. It is reported to be cross-reactive with Rhesus, Cynomolgus and Common marmoset CD86.

Hide

Product Details

Name PE Anti-Human CD86 (B7-2) (IT2.2)
Cat. No. 50-0869
Alternative Names B72, B70
Gene ID 942
Clone IT2.2
Isotype Mouse IgG2b, kappa
Reactivity Human
Cross Reactivity Cynomolgus, Common Marmoset, Rhesus
Format PE
Application Flow Cytometry
Citations*

Morgado P, Ong Y-C, Boothroyd JC, and Lodoen MB. 2011. Infect. Immun. 79: 4401-4412. (in vitro stimulation)

Kap YS, van Meurs M, van Driel N, Koopman G, Melief M-J, Brok HPM, Laman JD, and ‘t Hart BA. 2009. J. Histochemistry & Cytochemistry. 57: 1159-1167. (Immunohistochemistry – frozen tissue: Rhesus, Cynomolgus, Common marmoset)

Teleshova N, Kenney J, Willliams V, Van Nest G, Marshall J, Lifson LM, Sivin I, Dufour J, Bohm R, Gettie A, and Pope M. 2006. J. Leukoc. Ciol. 79:257-267. (Flow cytometry – rhesus macaque)

Conti L, Casetti R, Cardone M, Varano B, Martino A, Belardelli F, Poccia F, and Gessani S. 2005. J. Immunol. 174: 252-260. (Flow cytometry, in vitro blocking)

Esser MT, Graham DR, Coren LV, Trubey CM, Bess JW, Arthur LO, Ott DE, and Lifson JD. 2001. J. Virol. 75(13)6173-6182. (Western Blot)

Application Key:

FC = Flow Cytometry; FA = Functional Assays; ELISA = Enzyme-Linked Immunosorbent Assay; ICC = Immunocytochemistry; IF = Immunofluorescence Microscopy; IHC = Immunohistochemistry; IHC-F = Immunohistochemistry, Frozen Tissue; IHC-P = Immunohistochemistry, Paraffin-Embedded Tissue; IP = Immunoprecipitation; WB = Western Blot; EM = Electron Microscopy

*Tonbo Biosciences tests all antibodies by flow cytometry. Citations are provided as a resource for additional applications that have not been validated by Tonbo Biosciences. Please choose the appropriate format for each application and consult the Materials and Methods section for additional details about the use of any product in these publications.